Tuğba Gürbüz

Dr. Tuğba Gürbüz

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
BDBELGIN DEVRANOGLU
BELGIN DEVRANOGLU
TGTuğba Gürbüz
Tuğba Gürbüz
OGOya Gokmen
Oya Gokmen
This study assesses the efficacy of ChatGPT-4, an advanced artificial intelligence (AI) language model, in delivering precise and comprehensive answers to inquiries regarding managing polycystic ovary syndrome (PCOS)-related infertility. The research team, comprising experienced gynecologists, formulated 460 structured queries encompassing a wide range of common and intricate PCOS scenarios. The queries were: true/false (170), open-ended (165), and multiple-choice (125) and further classified as ‘easy’, ‘moderate’, and ‘hard’. For true/false questions, ChatGPT-4 achieved a flawless accuracy rate of 100% initially and upon reassessment after 30 days. In the open-ended category, there was a noteworthy enhancement in accuracy, with scores increasing from 5.53 ± 0.89 initially to 5.88 ± 0.43 at the 30-day mark (p < 0.001). Completeness scores for open-ended queries also experienced a significant improvement, rising from 2.35 ± 0.58 to 2.92 ± 0.29 (p < 0.001). In the multiple-choice category, although the accuracy score exhibited a minor decline from 5.96 ± 0.44 to 5.92 ± 0.63 after 30 days (p > 0.05). Completeness scores for multiple-choice questions remained consistent, with initial and 30-day means of 2.98 ± 0.18 and 2.97 ± 0.25, respectively (p > 0.05). ChatGPT-4 demonstrated exceptional performance in true/false queries and significantly improved handling of open-ended questions during the 30 days. These findings emphasize the potential of AI, particularly ChatGPT-4, in enhancing decision-making support for healthcare professionals managing PCOS-related infertility.


6 October 2021 in Cureus
Verified
Journal Article
Open access
TGTuğba Gürbüz
Tuğba Gürbüz
STSebnem Alanya Tosun
Sebnem Alanya Tosun
ACAysegul Cebi
Aysegul Cebi
OGOya Gokmen
Oya Gokmen
MUMurat Usta
Murat Usta
Polycystic ovary syndrome (PCOS) may have an increased risk for the development of systemic and metabolic pathogenesis such as cardiovascular diseases, insulin resistance (IR), diabetes mellitus (DM) and dyslipidemia. However, there is no reliable marker to show the relation. Fetuin-A is an adipokine whereas paraoxonase-1 (PON-1) is a high-density lipoprotein-linked enzyme to demonstrate oxidative stress. This study aimed to evaluate serum fetuin-A and PON-1 levels in infertile PCOS women based on body mass index (BMI). A prospective case-control study in a university setting was designed. A total of 88 patients admitted to the Giresun University Faculty of Medicine Gynecology Clinic between February and April 2021 were included in the study. The subjects were divided as follows: PCOS-low-BMI (BMI≤25) vs. Controls-low-BMI (BMI≤25) and PCOS-high-BMI (BMI>25) vs. Controls-high-BMI (BMI>25). Those who had at least two criteria of the 2003 Rotterdam Consensus were diagnosed with PCOS. Serum fetuin-A and PON-1 levels were compared. The mean levels of fetuin-A were not significantly different in the groups (p=0.955). Serum PON-1 levels were lower in the PCOS group (109.1±61.4 vs. 140.1±80.0; p=0.040), but it lost significance with adjusted values for covariants as age and BMI. Although PON-1 was not significantly different in the PCOS group of BMI<25 kg/m2 subgroup, it was significantly lower in the PCOS group of BMI≥25 kg/m2 subgroup (p=0.820 vs. p=0.048). Serum fetuin-A activity did not differ with PCOS. Serum PON-1 might be a promising and research-worthy marker, especially for obese PCOS patients.


21 January 2021 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
PDF file
TGTuğba Gürbüz
Tuğba Gürbüz
OGOya Gökmen
Oya Gökmen
GKGülten Kaptan
Gülten Kaptan
EIElif İnanli
Elif İnanli
SKSerkan Berk Karadeni̇z
Serkan Berk Karadeni̇z
ISİ̇brahim Söylemez
İ̇brahim Söylemez
Aim: Our study was aimed to investigate anxiety, depression, and obsessive-compulsive disorders (OCDs) among the pregnant women during Covid-19 Pandemic. Material and Method: This cross-sectional study was conducted on 71 pregnant women who referred to Gynecology and Obstetrics Clinic between June and July 2020 for routine pregnancy examination. The Beck Anxiety Inventory (BAI), the Beck Depression Inventory (BDI), and the Maudsley Obsessive-Compulsive Inventory (MOCI) were used to assess the rate of depression, anxiety, and OCDs. Results: Mean age was 30 years and the mean Body- Mass Index (BMI) was 24.4. 16.9% of the pregnants were normal, 46.5% were mild depression, 22.5% were moderate and 14.1% were severe depression. 31% of the pregnant women were mild, 45.1% were moderate and 23.9% were severe anxiety. The results also showed that 25.4% of the pregnants have a low probability of detecting OCDs, 31% had OCD detection and 43.7% had a high probability of detecting OCD. A positive significant relationship was found between BDI and BAI score (r=0.405, 0.000) and MOCI scale (r=0.319,sig= 0.007). A negative significant relationship was found between the MCOI scale and BMI (r=-0.268,sig=0.024). There was a significant difference between the working pregnants and non-working pregnants in terms of depression. Conclusion: Since the mental health of the pregnant women is highly important, one should pay special attention to the mental health of the working pregnant women under the Covid-19 pandemic. The reason is that such women are more vulnerable to the infectious diseases such as Covid-19.

1 March 2021 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
NGNUR DOKUZEYLÜL GÜNGÖR
NUR DOKUZEYLÜL GÜNGÖR
TGTuğba Gürbüz
Tuğba Gürbüz
TTTugba Ture
Tugba Ture
Pruritic urticarial papules and plaques of pregnancy development may have a strong relationship with hormone treatments during in vitro fertilization and hormonal changes during pregnancy. The aim of this study was to evaluate and compare the frequency of papules and plaques of pregnancy and related factors in in vitro fertilization pregnancies and spontaneous pregnancies. In this study, 517 in vitro fertilization pregnancies and 1253 spontaneous pregnancies were retrospectively reviewed for papules and plaques of pregnancy frequency. The diagnosis of papules and plaques of pregnancy was performed by referral to the dermatology department and according to the typical clinical manifestations of the disease. The papules and plaques of pregnancy was more common in all in vitro fertilization pregnancies (including single pregnancies) than in spontaneous pregnancies. Age, Rh positivity, mother weight gain, onset of disease during gestation, duration of disease, birth weight and the frequency of male fetus were similar between the two groups (p>0.05). The rate of multiple pregnancies was higher in in vitro fertilization pregnancies with papules and plaques of pregnancy than in vitro fertilization pregnancies without papules and plaques of pregnancy (p<0.001). Duration of progesterone treatment was also significantly longer in in vitro fertilization pregnancies with papules and plaques of pregnancy compared to in vitro fertilization pregnancies without papules and plaques of pregnancy (p<0.001). The limitations of the study were the retrospective and single-centered design. The results of this study indicate that increased progesterone dosage or prolonged treatment may play a role in the pathogenesis papules and plaques of pregnancy.